MK2 Inhibition in CD4+ T Cells Protects Against IFNγ and IL-17A, Chronic Inflammation, and Fibrosis in Inflammatory Bowel Disease Models

在炎症性肠病模型中，CD4+ T细胞中的MK2抑制可抵抗IFNγ和IL-17A、慢性炎症和纤维化。